Literature DB >> 16734442

Transition state analogue discrimination by related purine nucleoside phosphorylases.

Erika A Taylor Ringia1, Peter C Tyler, Gary B Evans, Richard H Furneaux, Andrew S Murkin, Vern L Schramm.   

Abstract

Transition state analogues of PNP, the Immucillins and DADMe-Immucillins, were designed to match transition state features of bovine and human PNPs, respectively. The inhibitors with or without the hydroxyl and hydroxymethyl groups of the substrate demonstrate that inhibitor geometry mimicking that of the transition state confers binding affinity discrimination. This finding is remarkable since crystallographic analysis indicates complete conservation of active site residues and contacts to ligands in human and bovine PNPs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16734442      PMCID: PMC2518100          DOI: 10.1021/ja061403n

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  15 in total

1.  Determining transition states from kinetic isotope effects.

Authors:  P J Berti
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Improved Syntheses of 3H,5H-Pyrrolo[3,2-d]pyrimidines.

Authors:  Richard H. Furneaux; Peter C. Tyler
Journal:  J Org Chem       Date:  1999-10-29       Impact factor: 4.354

3.  Energetic mapping of transition state analogue interactions with human and Plasmodium falciparum purine nucleoside phosphorylases.

Authors:  Andrzej Lewandowicz; Erika A Taylor Ringia; Li-Min Ting; Kami Kim; Peter C Tyler; Gary B Evans; Olga V Zubkova; Simon Mee; Gavin F Painter; Dirk H Lenz; Richard H Furneaux; Vern L Schramm
Journal:  J Biol Chem       Date:  2005-06-16       Impact factor: 5.157

4.  The use of isotope effects to determine transition-state structure for enzymic reactions.

Authors:  W W Cleland
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

Review 5.  Purine nucleoside phosphorylase inhibitors in T-cell malignancies.

Authors:  Shanta Bantia; John Michael Kilpatrick
Journal:  Curr Opin Drug Discov Devel       Date:  2004-03

6.  Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis.

Authors:  A Fedorov; W Shi; G Kicska; E Fedorov; P C Tyler; R H Furneaux; J C Hanson; G J Gainsford; J Z Larese; V L Schramm; S C Almo
Journal:  Biochemistry       Date:  2001-01-30       Impact factor: 3.162

7.  Achieving the ultimate physiological goal in transition state analogue inhibitors for purine nucleoside phosphorylase.

Authors:  Andrzej Lewandowicz; Peter C Tyler; Gary B Evans; Richard H Furneaux; Vern L Schramm
Journal:  J Biol Chem       Date:  2003-07-03       Impact factor: 5.157

8.  One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.

Authors:  R W Miles; P C Tyler; R H Furneaux; C K Bagdassarian; V L Schramm
Journal:  Biochemistry       Date:  1998-06-16       Impact factor: 3.162

9.  Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase.

Authors:  Gary B Evans; Richard H Furneaux; Andrzej Lewandowicz; Vern L Schramm; Peter C Tyler
Journal:  J Med Chem       Date:  2003-07-17       Impact factor: 7.446

Review 10.  Enzymatic transition state poise and transition state analogues.

Authors:  Vern L Schramm
Journal:  Acc Chem Res       Date:  2003-08       Impact factor: 22.384

View more
  14 in total

1.  Slow conformational motions that favor sub-picosecond motions important for catalysis.

Authors:  J R Exequiel T Pineda; Dimitri Antoniou; Steven D Schwartz
Journal:  J Phys Chem B       Date:  2010-11-15       Impact factor: 2.991

2.  Transition state analysis of model and enzymatic prenylation reactions.

Authors:  Stepan Lenevich; Juhua Xu; Ayako Hosokawa; Christopher J Cramer; Mark D Distefano
Journal:  J Am Chem Soc       Date:  2007-04-17       Impact factor: 15.419

3.  Inhibition and structure of Trichomonas vaginalis purine nucleoside phosphorylase with picomolar transition state analogues.

Authors:  Agnes Rinaldo-Matthis; Corin Wing; Mahmoud Ghanem; Hua Deng; Peng Wu; Arti Gupta; Peter C Tyler; Gary B Evans; Richard H Furneaux; Steven C Almo; Ching C Wang; Vern L Schramm
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

4.  Transition-state structure of neisseria meningitides 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase.

Authors:  Vipender Singh; Minkui Luo; Rosemary L Brown; Gillian E Norris; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2007-10-23       Impact factor: 15.419

5.  Altered enthalpy-entropy compensation in picomolar transition state analogues of human purine nucleoside phosphorylase.

Authors:  Achelle A Edwards; Jennifer M Mason; Keith Clinch; Peter C Tyler; Gary B Evans; Vern L Schramm
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

6.  Design and directed evolution of a dideoxy purine nucleoside phosphorylase.

Authors:  David P Nannemann; Kristian W Kaufmann; Jens Meiler; Brian O Bachmann
Journal:  Protein Eng Des Sel       Date:  2010-06-04       Impact factor: 1.650

7.  Third-generation immucillins: syntheses and bioactivities of acyclic immucillin inhibitors of human purine nucleoside phosphorylase.

Authors:  Keith Clinch; Gary B Evans; Richard F G Fröhlich; Richard H Furneaux; Peter M Kelly; Laurent Legentil; Andrew S Murkin; Lei Li; Vern L Schramm; Peter C Tyler; Anthony D Woolhouse
Journal:  J Med Chem       Date:  2009-02-26       Impact factor: 7.446

Review 8.  Catalytic scaffolds for phosphoryl group transfer.

Authors:  Karen N Allen; Debra Dunaway-Mariano
Journal:  Curr Opin Struct Biol       Date:  2016-08-13       Impact factor: 6.809

9.  QM/MM study of thymidylate synthase: enzymatic motions and the temperature dependence of the rate limiting step.

Authors:  Natalia Kanaan; Sergio Martí; Vicent Moliner; Amnon Kohen
Journal:  J Phys Chem A       Date:  2009-03-12       Impact factor: 2.781

10.  Enzymatic transition states and dynamic motion in barrier crossing.

Authors:  Steven D Schwartz; Vern L Schramm
Journal:  Nat Chem Biol       Date:  2009-08       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.